Literature DB >> 29110594

Ligand and Structure-based Modeling of Passive Diffusion through the Blood-Brain Barrier.

Santiago Vilar1, Eduardo Sobarzo-Sanchez1,2, Lourdes Santana1, Eugenio Uriarte1,3.   

Abstract

BACKGROUND: Blood-brain barrier transport is an important process to be considered in drug candidates. The blood-brain barrier protects the brain from toxicological agents and, therefore, also establishes a restrictive mechanism for the delivery of drugs into the brain. Although there are different and complex mechanisms implicated in drug transport, in this review we focused on the prediction of passive diffusion through the blood-brain barrier.
METHODS: We elaborated on ligand-based and structure-based models that have been described to predict the blood-brain barrier permeability.
RESULTS: Multiple 2D and 3D QSPR/QSAR models and integrative approaches have been published to establish quantitative and qualitative relationships with the blood-brain barrier permeability. We explained different types of descriptors that correlate with passive diffusion along with data analysis methods. Moreover, we discussed the applicability of other types of molecular structure-based simulations, such as molecular dynamics, and their implications in the prediction of passive diffusion. Challenges and limitations of experimental measurements of permeability and in silico predictive methods were also described.
CONCLUSION: Improvements in the prediction of blood-brain barrier permeability from different types of in silico models are crucial to optimize the process of Central Nervous System drug discovery and development. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Keywords:  Blood-Brain barrier; QSAR; central nervous system; mechanism.; molecular descriptors; molecular dynamics

Mesh:

Substances:

Year:  2018        PMID: 29110594     DOI: 10.2174/0929867324666171106163742

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  1-Hydroxy-2(1H)-pyridinone-Based Chelators with Potential Catechol O-Methyl Transferase Inhibition and Neurorescue Dual Action against Parkinson's Disease.

Authors:  Joseph C J Bergin; Kean Kan Tan; Anya K Nelson; Cristina-Andreea Amarandei; Véronique Hubscher-Bruder; Jérémy Brandel; Varvara Voinarovska; Annick Dejaegere; Roland H Stote; David Tétard
Journal:  Molecules       Date:  2022-04-28       Impact factor: 4.927

2.  Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning.

Authors:  Rui Miao; Liang-Yong Xia; Hao-Heng Chen; Hai-Hui Huang; Yong Liang
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.